Recent News

By Category: Bioterrorism

HHS Taps Rempex for Biothreat, Antimicrobial Defense Drug

(HHS) The Department of Health and Human Services will invest up to $90 million over five years in a partnership with Rempex Pharmaceuticals to further develop an experimental drug against biothreat pathogens and drug-resistant bacteria. HHS’ Biomedical Advanced Research and Development Authority will initially put forth $19.8 million to support Rempex’s research and development of  Read More »

U.S. Seeks New Tools to Fight Hardiest Bacteria

(National Journal) The U.S. Defense Department is seeking scientists to pursue new drug technology for fighting the hardiest bacteria with bioterrorism potential, USA Today reports. The Pentagon’s Defense Threat Reduction Agency this week issued a request for information on the possible creation of “small organic molecules inhibitors” to fight multiple-drug-resistant bacteria, including those designated as  Read More »

BARDA Funds Countermeasure for Burkholderia Infections

(Global Biodefense) A new drug to help protect the public against two bioterrorism threats and provide a new option to treat antibiotic-resistant infections will advance in development under a public-private partnership, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) announced this week.

Information On US Bioweapons Tests In Japan Met With Ambivalent Reaction

(Eurasia Review) Information about the US conducting field experiments of biological weapons in the Japanese island of Okinawa in early 1960s once again attracted the attention of international politicians and experts to the problem of bioterrorism, and provoked mixed reaction in the world. According to Japan’s leading news network Kyodo News that obtained US documents,  Read More »

Par panel suggests wider consultation on agri-biosecurity bill | Business Standard